Critical factors for the reversal of methotrexate cytotoxicity by folinic acid.

Por Bernard, S., Etienne, M. C., Fischel, J. L., Formento, P., Milano, G.
Publicado em 1991

Impact of thymidine phosphorylase surexpression on fluoropyrimidine activity and on tumour angiogenesis

Por Marchetti, S, Chazal, M, Dubreuil, A, Fischel, J L, Etienne, M C, Milano, G
Publicado em 2001

Ternary combination of irinotecan, fluorouracil-folinic acid and oxaliplatin: results on human colon cancer cell lines

Por Fischel, J-L, Rostagno, P, Formento, P, Dubreuil, A, Etienne, M-C, Milano, G
Publicado em 2001

Dihydropyrimidine dehydrogenase deficiency and fluorouracil-related toxicity

Por Milano, G, Etienne, M C, Pierrefite, V, Barberi-Heyob, M, Deporte-Fety, R, Renée, N
Publicado em 1999

Evidence for CSF accumulation of 5-methyltetrahydrofolate during repeated courses of methotrexate plus folinic acid rescue.

Por Thyss, A., Milano, G., Etienne, M. C., Paquis, P., Roche, J. L., Grelier, P., Schneider, M.
Publicado em 1989

Impact of the oxaliplatin-5 fluorouracil-folinic acid combination on respective intracellular determinants of drug activity

Por Fischel, J L, Formento, P, Ciccolini, J, Rostagno, P, Etienne, M C, Catalin, J, Milano, G
Publicado em 2002

No effect of dose, hepatic function, or nutritional status on 5-FU clearance following continuous (5-day), 5-FU infusion.

Por Fleming, R. A., Milano, G. A., Etienne, M. C., Renée, N., Thyss, A., Schneider, M., Demard, F.
Publicado em 1992

Thymidylate synthase expression and activity: relation to S-phase parameters and 5-fluorouracil sensitivity.

Por Mirjolet, J. F., Barberi-Heyob, M., Merlin, J. L., Marchal, S., Etienne, M. C., Milano, G., Bey, P.
Publicado em 1998

Dose reduction without loss of efficacy for 5-fluorouracil and cisplatin combined with folinic acid. In vitro study on human head and neck carcinoma cell lines.

Por Etienne, M. C., Bernard, S., Fischel, J. L., Formento, P., Gioanni, J., Santini, J., Demard, F., Schneider, M., Milano, G.
Publicado em 1991

Thymidylate synthase and methylenetetrahydrofolate reductase gene polymorphisms: relationships with 5-fluorouracil sensitivity

Por Etienne, M-C, Ilc, K, Formento, J-L, Laurent-Puig, P, Formento, P, Cheradame, S, Fischel, J-L, Milano, G
Publicado em 2004

Tamoxifen metabolism: pharmacokinetic and in vitro study.

Por Etienne, M. C., Milano, G., Fischel, J. L., Frenay, M., François, E., Formento, J. L., Gioanni, J., Namer, M.
Publicado em 1989

Optimised analysis of tamoxifen and its main metabolites in the plasma and cytosol of mammary tumours.

Por Milano, G., Etienne, M. C., Frenay, M., Khater, R., Formento, J. L., Renee, N., Moll, J. L., Francoual, M., Berto, M., Namer, M.
Publicado em 1987

Molecular mechanisms underlying the interaction between ZD1839 (‘Iressa’) and cisplatin/5-fluorouracil

Por Magné, N, Fischel, J-L, Tiffon, C, Formento, P, Dubreuil, A, Renée, N, Formento, J-L, Francoual, M, Ciccolini, J, Etienne, M-C, Milano, G
Publicado em 2003

Application of an original RT-PCR–ELISA multiplex assay for MDR1 and MRP, along with p53 determination in node-positive breast cancer patients

Por Ferrero, J M, Etienne, M C, Formento, J L, Francoual, M, Rostagno, P, Peyrottes, I, Ettore, F, Teissier, E, Leblanc-Talent, P, Namer, M, Milano, G
Publicado em 2000

A multifactorial approach including tumoural epidermal growth factor receptor, p53, thymidylate synthase and dihydropyrimidine dehydrogenase to predict treatment outcome in head an...

Por Etienne, M C, Pivot, X, Formento, J L, Bensadoun, R J, Formento, P, Dassonville, O, Francoual, M, Poissonnet, G, Fontana, X, Schneider, M, Demard, F, Milano, G
Publicado em 1999